Hospital Acquired Infection Treatment Market Research Report: Market Competition, Value Chain Analysis and Forecast 2024
The global market for hospital acquired infection (HAI) treatment features an exceedingly fragmented vendor landscape, with no leading vendor accounting for a dominant share in the market in 2015, observes Transparency Market Research in a recent report. Notable players in the market, including Merck & Co., Inc., Abbott, Bayer AG, and Pfizer, Inc., struggle for profitable returns amid the emerging threat of generics following patent expirations of several blockbuster drugs.
View full press release